The document shows the number of life science initial public offerings (IPOs) from 2000 to 2017, with peaks in 2000, 2006-2007, and lower levels during economic downturns and periods of uncertainty like the dot-com crash, recessions, and the Affordable Care Act. The number of life science IPOs has increased recently after a low point in 2013-2015.